interferon-gamma has been researched along with jnj 10181457 in 1 studies
| Studies (interferon-gamma) | Trials (interferon-gamma) | Recent Studies (post-2010) (interferon-gamma) | Studies (jnj 10181457) | Trials (jnj 10181457) | Recent Studies (post-2010) (jnj 10181457) |
|---|---|---|---|---|---|
| 8 | 0 | 4 | 7 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apodaca, R; Barbier, AJ; Boggs, JD; Bonaventure, P; Carruthers, NI; Dvorak, LK; Feinstein, M; Lord, B; Lovenberg, TW; Mazur, C; Morton, K; Shah, CR; Swanson, DM; Wilson, SJ; Xiao, W | 1 |
1 other study(ies) available for interferon-gamma and jnj 10181457
| Article | Year |
|---|---|
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.
Topics: Animals; Blood-Brain Barrier; Cell Line; Diamines; Histamine H3 Antagonists; Humans; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3 | 2009 |